Editorial · Oct 2021
Conference abstract
Geriatric Drug Development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This talk discusses biopharmaceutical (drug) development for older adults, including considerations in Phase I (clinical pharmacology), Phase II/III (clinical development), marketing authorization (labeling), and Phase IV (postmarketing risk evaluation and mitigation strategies or risk minimization). After participating in this activity, participants will: (1) Know the key age-associated changes in pharmacokinetics and pharmacodynamics under consideration when developing drugs for older adults - The purpose of Phase I (clinical pharmacology) drug trials in older adults is to determine if there are relevant ageassociated changes in pharmacokinetics (absorption, distribution, metabolism, and elimination) and/or pharmacodynamics; (2) Understand why older adults are frequently excluded from clinical trials - There is a shortage of studies focusing on older adults, so clinicians and policy makers frequently rely on clinical trials of the general population to provide supportive evidence for treating complex, older patients. This talk details the challenges of including frail, older adults in clinical trials; (2) Describe different types of product labeling - The talk will review different aspects of product labeling for both healthcare providers and patients/caregivers. The basic rules that govern advertising for prescription drugs, including direct-to-consumer (DTC) advertising, will also be discussed; and (4) Be aware of current and future approaches to understanding drug safety (and effectiveness) in older adults - The speaker will discuss the implications of recent regulatory initiatives and global trends on the safe and effective use of drugs in older adults.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2017
Use of Drugs Prolonging QT Interval in Patients at the Time of Admission to Geriatric Department
Perspective · 30 May 2022
Geriatric Diabetes Guideline Development
Editorial · 28 Jan 2022
2nd International Conference on Drug Discovery, Design and Development
Editorial · 31 Jan 2022
Announcement of 2nd International Conference on Geriatrics
More from this journal
The newest in Gerontology & Geriatric Research.
Article · 24 Jan 2025
The Mechanisms of How Plant-Based Diets and Dietary Supplements Reduce COVID-19 Severity and Achieve Zero Mortality in High-Risk Elderly Patients
Article · 24 Jan 2025
The Caregiving Chronicles: Balancing Acts and Emotional Challenges in Cancer Care
Article · 24 Jan 2025
Plant-Based Diets and Supplements Reduced COVID-19 Severity with Zero Mortality in High-Risk Elderly Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGerontology & Geriatric Research
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Helen K Edelberg”

